6
Participants
Start Date
June 30, 2014
Primary Completion Date
July 31, 2017
Study Completion Date
July 31, 2017
Brentuximab vedotin
Day 1 every three weeks (weeks 0, 3, 6, 9, ... 27): 1.8 mg/kg IV. Ten doses maximum.
Rituximab
Day 1 of weeks 12, 13, 14, 15, 18, 21, 24, and 27: 375 mg/m\^2 IV. Additional doses are given at three and six months post week 27.
The Sidney Kimmel Comprehensive Canceer Center, Baltimore
Collaborators (1)
Genentech, Inc.
INDUSTRY
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER